AVROBIO, Inc. Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) — AVROBIO, Inc. (NASDAQ: AVRO), (“The Company”) a Phase 2 clinical-stage gene therapy […]
Resonant Inc. Signs New License Agreement with a Leading Chinese Optoelectronics Company that has Targeted the RFFE Market for Expanded Growth
New customer selects Resonant to shorten time to market for a high performance quadplexer design Becoming second customer to leverage […]
SFL – $270 million lease financing for 3 x 10,600 TEU container vessels and delivery of Front Falcon
Ship Finance International Limited (NYSE: SFL) (“Ship Finance” or the “Company”) announces that it has entered into lease financing agreements […]
Mechel Buys 150 New Railcars to Transport Coal
MOSCOW, Dec. 18, 2018 (GLOBE NEWSWIRE) — Mechel PAO (MOEX: MTLR, NYSE: MTL), one of the leading Russian mining and […]
Neuralstem Appoints Ken Carter, Ph.D., as Executive Chairman of the Board
– Seasoned biotech executive and accomplished scientific leader with broad experience from early-stage company development to managing publicly traded entities […]
LGI Homes Expands Presence in Greater Sacramento
Homebuilder debuts new homes in Northern California priced from the high-$200s OLIVEHURST, Calif., Dec. 18, 2018 (GLOBE NEWSWIRE) — LGI […]
AVROBIO, Inc. Expands and Strengthens Leadership Team with Four Senior Management Hires
Birgitte Volck, M.D., Ph.D., is appointed President of Research and Development and will oversee clinical, regulatory, research and manufacturing CAMBRIDGE, […]
Axsome Therapeutics to Present at Biotech Showcase 2019
NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies […]
Colony Bankcorp Signs Definitive Agreement to Acquire LaGrange, Georgia-Based LBC Bancshares, Inc.
FITZGERALD, Ga., Dec. 18, 2018 (GLOBE NEWSWIRE) — Colony Bankcorp, Inc. (Nasdaq: CBAN) (“Colony” or “the Company”), the holding company […]
Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement
NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage […]
